S&CO Inc. Purchases Shares of 5,121 Intuitive Surgical, Inc. $ISRG

S&CO Inc. purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 5,121 shares of the medical equipment provider’s stock, valued at approximately $2,036,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in ISRG. Prosperity Consulting Group LLC grew its stake in shares of Intuitive Surgical by 0.5% in the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after buying an additional 19 shares in the last quarter. WoodTrust Financial Corp raised its position in Intuitive Surgical by 0.5% during the fourth quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock worth $2,367,000 after acquiring an additional 20 shares in the last quarter. North Star Investment Management Corp. raised its position in Intuitive Surgical by 8.5% during the fourth quarter. North Star Investment Management Corp. now owns 269 shares of the medical equipment provider’s stock worth $152,000 after acquiring an additional 21 shares in the last quarter. Cornerstone Planning Group LLC lifted its stake in Intuitive Surgical by 11.5% in the fourth quarter. Cornerstone Planning Group LLC now owns 203 shares of the medical equipment provider’s stock valued at $106,000 after acquiring an additional 21 shares during the last quarter. Finally, Valeo Financial Advisors LLC lifted its stake in Intuitive Surgical by 0.4% in the fourth quarter. Valeo Financial Advisors LLC now owns 4,941 shares of the medical equipment provider’s stock valued at $2,798,000 after acquiring an additional 21 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $394.51 on Friday. The firm has a market cap of $139.37 billion, a P/E ratio of 45.19, a price-to-earnings-growth ratio of 2.85 and a beta of 1.46. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The firm’s 50-day simple moving average is $391.45 and its 200 day simple moving average is $441.28.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same period last year, the business posted $1.81 earnings per share. The business’s revenue for the quarter was up 18.4% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Gary S. Guthart sold 10,000 shares of the company’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total value of $4,000,000.00. Following the transaction, the director directly owned 1,245,679 shares of the company’s stock, valued at $498,271,600. This represents a 0.80% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares in the company, valued at $2,718,014.65. The trade was a 46.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,106 shares of company stock worth $6,949,518 in the last ninety days. 0.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on ISRG shares. Mizuho set a $500.00 price objective on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. KeyCorp reissued an “overweight” rating on shares of Intuitive Surgical in a research report on Wednesday. Raymond James Financial restated an “outperform” rating and issued a $483.00 price objective (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Bank of America reduced their target price on Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $487.00 price target (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $508.68.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.